Synthetic HLA-A2 derived peptides are recognized and presented in renal graft recipients.
Indirect presentation of allogeneic MHC antigen is an important pathway by which allografts are rejected and tolerance maintained by regulatory CD4(+) T cells. In this study HLA-A2 derived synthetic peptides were used to determine whether T cells of non-HLA-A2 renal graft recipients, which had been HLA-A2 mismatched to their organ donors, recognize some of the HLA-A2-derived peptides. Among the HLA-A2 mismatched patients, 60% recognized residues 56--69, 65--79, and 75--89. Peripheral blood lymphocytes derived from healthy individuals showed low reactivity towards allopeptides, indicating that sensitization towards HLA-A2 induced response towards HLA-A2 derived peptides. The response to the peptides was blocked by antibodies to HLA-DR, -DQ, and CD4. Depletion of antigen presenting cells abrogated response towards the allopeptides, confirming that the observed proliferation was mediated by the indirect pathway. Interestingly, although none of the HLA-A2 mismatched patients had any signs for either acute or chronic rejection, considerable response to allo-derived HLA-A2 was observed.
Stegmann
S
S
Institute of Immunology, University of Kiel, Kiel, Germany.
Müller
A
A
Zavazava
N
N
D000595:Amino Acid Sequence; D017951:Antigen Presentation / Q000187:drug effects / Q000276:immunology*; D015789:HLA-A2 Antigen / Q000378:metabolism*; D006650:Histocompatibility Testing; D006801:Humans; D006825:Hybridomas; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D020014:K562 Cells; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects / Q000276:immunology; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000276:immunology* / Q000378:metabolism*; D011184:Postoperative Period; D014407:Tumor Cells, Cultured
D015789:HLA-A2 Antigen; D007166:Immunosuppressive Agents; D010446:Peptide Fragments